Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Novel Technique Developed for Screening Proteins

12/8/2010

Benjamin F. Cravatt III, Ph.D., Professor and Chair, Department of Chemical Physiology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA

A team led by researchers from The Scripps Research Institute has developed a new method for detecting functional sites on proteins. The technique may have broad applications in basic research and drug development, according to the scientists. Described online in Nature on November 17, the method enables scientists to take a sample of cells, locate the sites on their proteins that have a certain kind of biochemical reactivity, and measure the degree of that reactivity.


During this week’s podcast Dr Benjamin Cravatt III, senior investigator of the Nature study, describes how scientists currently try to detect functional sites on proteins and why a new approach is needed. He discusses the uniqueness of the newly developed protein screening technology and what it enables researchers to do now that they were not able to do in the past. He also talks about the range of patenting applications for the novel protein screening technique.

Dr. Benjamin Cravatt is currently professor and chair of the department of chemical physiology and co-director of the Center for Physiological Proteomics at The Scripps Research Institute. Dr. Cravatt’s research interests focus on developing and applying new technologies to elucidate the roles that enzymes play in physiological and pathological processes, especially as they pertain to the nervous system and cancer.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll